AI generated summary of Pubmed citation/abstract with PMID 38091892

https://pubmed.ncbi.nlm.nih.gov/38091892

Novel UDCA-aminopyrimidine hybrids, 12a and 12h, show promising potential as anti-fibrotic agents by inhibiting the TGF-β/Smad signaling pathway in hepatic and pulmonary fibrosis.